1-Bromo-3,5-difluorobenzene | CAS:461-96-1

We serve 1-Bromo-3,5-difluorobenzene CAS:461-96-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-3,5-difluorobenzene

Chemical Name:1-Bromo-3,5-difluorobenzene
CAS.NO:461-96-1
Synonyms:1-Bromo-3,5-difluorobenzene
3,5-difluoro-1-bromobenzene
4-bromo-2,6-difluorobenzene
1-bromo-3,5-difluoro-benzene
3,5-Difluorobromobenzene
Molecular Formula:C6H3BrF2
Molecular Weight:192.98900
 
Physical and Chemical Properties:
Density:1.676
Melting point:-27ºC
Boiling point:140ºC
Flash point:112°F
Index of Refraction:1.499
 
Specification:
Appearance:Colorless liquid
Assay:≥99.0%
Moisture:≤0.1%
Single impurity:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical and liquid crystal material intermediate



Contact us for information like 1-Bromo-3,5-difluorobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Difluorobromobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-difluoro-1-bromobenzene Use and application,1-bromo-3,5-difluoro-benzene technical grade,usp/ep/jp grade.


Related News: 2-Fluoro-4-methoxybenzoic acid manufacturer 2,7-dibromo-9,9-diphenylfluorene supplier Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.Raspberry ketone glucoside vendor Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.Another prominent coronavirus to emerge since the turn of the century is Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012 and killed more than 800 people.